Laboratory of Lymphocyte Signaling and Oncoproteome

Consensus guidelines for T-PLL published

Although T-cell prolymphocytic leukemia had already been recognized being distinct from CLL in 1976, until today it has been managed according to criteria for CLL as described by the international workshop on CLL (IWCLL). The T-PLL International Study group (TPLL-ISG) has now set up a first consensus paper defining guidelines for the diagnosis, treatment and response evaluation of T-PLL. These guidelines will provide a basis for clinical decision making and will help to compare results from clinical trials in T-PLL.

Click here to read the article

Postet on July 15, 2019

More news

Future therapies in T-PLL and T-LGL

Future therapies in T-PLL and T-LGL

June 7, 2021

New perspective on future targeted therapy approaches published.

New article accepted for publication

New article accepted for publication

August 30, 2020

Our work on T-PLL cells resembling the phenotype of activated memory-type effector T-cells has been accepted in Blood